Telmisartan in Mild to Moderate Hypertensive Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and tolerability of telmisartan, given once a day to patients with
mild to moderate hypertension, as well as to assess the 24-hour blood pressure profile with
ABPM